{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:33Z","timestamp":1790223393663,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2861,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1038\/sj.jid.5701027","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:23:06Z","timestamp":1187864586000},"page":"473-480","source":"Crossref","is-referenced-by-count":15,"title":["IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with S\u00e9zary Syndrome"],"prefix":"10.1016","volume":"128","author":[{"given":"Jessica S.","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice M.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasprzycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz A.","family":"Wasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5701027_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1523-1747.ep12514693","article-title":"A clonal CD4-positive T-cell line established from the blood of a patient with Sezary syndrome","volume":"96","author":"Abrams","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5701027_bb0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.175.2.755","article-title":"IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells","volume":"175","author":"Alves","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0020","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.0022-202X.2005.23914.x","article-title":"Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in Sezary syndrome patients","volume":"125","author":"Bouaziz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5701027_bb0025","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.4049\/jimmunol.172.4.2048","article-title":"IL-21 induces the functional maturation of murine NK cells","volume":"172","author":"Brady","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0030","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1586\/14737140.6.6.905","article-title":"Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma","volume":"6","author":"Curti","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/sj.jid.5701027_bb0040","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0045","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.172.3.1540","article-title":"IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice","volume":"172","author":"DiCarlo","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0050","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis","volume":"173","author":"Jin","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5701027_bb0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(02)00295-9","article-title":"IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity","volume":"16","author":"Kasaian","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/sj.jid.5701027_bb0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1525-0016(03)00222-3","article-title":"Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma","volume":"8","author":"Kishida","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/sj.jid.5701027_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2567.2000.00964.x","article-title":"CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12","volume":"99","author":"Kranzer","year":"2000","journal-title":"Immunology"},{"key":"10.1038\/sj.jid.5701027_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune Surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0085","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.4049\/jimmunol.136.12.4480","article-title":"The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes","volume":"136","author":"Lanier","year":"1986","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1688","article-title":"Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation","volume":"5","author":"Leonard","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0095","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.171.2.608","article-title":"IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma","volume":"171","author":"Ma","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archderm.141.9.1176","article-title":"The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sezary syndrome","volume":"141","author":"McGinnis","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5701027_bb0105","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","article-title":"IL-21 induces the apoptosis of resting and activated primary B cells","volume":"170","author":"Mehta","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.173.2.900","article-title":"IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21","volume":"173","author":"Moroz","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0115","first-page":"131","article-title":"Cutaneous T-cell lymphoma","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv Pathol"},{"key":"10.1038\/sj.jid.5701027_bb0120","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6","volume":"173","author":"Ozaki","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5701027_bb0130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1189\/jlb.72.5.856","article-title":"Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses","volume":"72","author":"Parrish-Novak","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1038\/sj.jid.5701027_bb0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8588(18)30054-6","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma","volume":"9","author":"Rook","year":"1995","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1038\/sj.jid.5701027_bb0140","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in Sezary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/sj.jid.5701027_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.jidsp.5640188","article-title":"Photopheresis: clinical applications and mechanism of action","volume":"4","author":"Rook","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/sj.jid.5701027_bb0150","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001622-199803000-00015","article-title":"Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma","volume":"10","author":"Rook","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/sj.jid.5701027_bb0160","first-page":"40","article-title":"Simultaneous determination of cell surface antigens and apoptosis","volume":"10","author":"Sgonc","year":"1994","journal-title":"Trends Genet"},{"key":"10.1038\/sj.jid.5701027_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0170","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5701027_bb0175","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1084\/jem.188.12.2335","article-title":"Type I interferon-mediated stimulation of T cells by CpG DNA","volume":"188","author":"Sun","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5701027_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2141.2004.05255.x","article-title":"Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells","volume":"128","author":"Ueda","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1038\/sj.jid.5701027_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.cgt.7700552","article-title":"Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts","volume":"10","author":"Ugai","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.jid.5701027_bb0190","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.cgt.7700630","article-title":"Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects","volume":"10","author":"Ugai","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.jid.5701027_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-642-59410-6_37","article-title":"New biological response modifiers in the treatment of cutaneous T-cell lymphoma","volume":"160","author":"Vittorio","year":"2002","journal-title":"Recent Res Cancer Res"},{"key":"10.1038\/sj.jid.5701027_bb0200","first-page":"9016","article-title":"In vivo antitumor activity of interleukin 21 mediated by natural killer cells","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5701027_bb0205","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1182\/blood-2006-09-045278","article-title":"Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation and proliferation in CD8 T cells of patients infected with human immunodeficiency virus-1 (HIV)","volume":"109","author":"White","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0210","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG-oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0215","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5701027_bb0220","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1067\/mjd.2001.116345","article-title":"Complete molecular remission during biologic response modifier therapy for Sezary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity","volume":"45","author":"Yoo","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5701027_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"}],"updated-by":[{"DOI":"10.1038\/sj.jid.5701194","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000}}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15337416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15337416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T14:52:18Z","timestamp":1708181538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15337416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0022202X15337416"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5701027","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}